v3.24.1.u1
EQUITY AND NONCONTROLLING INTERESTS (Tables)
 3 Months Ended
Mar. 30, 2024
Equity [Abstract]  
Reconciliation of the Numerator and Denominator in the Computations of the Basic and Diluted Earnings Per Share
The following table reconciles the numerator and denominator in the computations of basic and diluted earnings per share:
Three Months Ended
March 30, 2024April 1, 2023
(in thousands)
Numerator:
Net income$74,482 $103,954 
Less: Net income attributable to noncontrolling interests1,522 823 
Net income available to Charles River Laboratories International, Inc.
72,960 103,131 
Less: Adjustment of redeemable noncontrolling interest (1)
401 — 
Less: Incremental dividends attributable to noncontrolling interest holders (2)
5,230 — 
Net income available to Charles River Laboratories International, Inc. common shareholders
$67,329 $103,131 
Denominator:
Weighted-average shares outstanding - Basic51,437 51,097 
Effect of dilutive securities:
Stock options, restricted stock units and performance share units405 331 
Weighted-average shares outstanding - Diluted51,842 51,428 
Anti-dilutive common stock equivalents (3)
448 405 
(1) Represents adjustments of redeemable noncontrolling interest that impact retained earnings.
(2) Represents incremental undeclared dividends attributable to Noveprim noncontrolling interest holders who are entitled to preferential dividends for fiscal year 2024.
(3) These common stock equivalents were outstanding for the periods presented, but were not included in the computation of diluted EPS for those periods because their inclusion would have had an anti-dilutive effect.
Schedule of Accumulated Other Comprehensive Income (Loss)
Changes to each component of accumulated other comprehensive income (loss), net of income taxes, are as follows:
Foreign Currency Translation Adjustment
and Other 		Pension and Other Post-Retirement Benefit PlansNet Unrealized (Loss) Gain on Cash Flow HedgeTotal
(in thousands)
December 30, 2023$(149,999)$(47,167)$739 $(196,427)
Other comprehensive income (loss) before reclassifications
(60,077)344 768 (58,965)
Net current period other comprehensive income (loss)
(60,077)344 768 (58,965)
Income tax expense (benefit)(5,737)80 184 (5,473)
March 30, 2024$(204,339)$(46,903)$1,323 $(249,919)